Alpine Global Management LLC bought a new stake in shares of Quantum-Si incorporated (NASDAQ:QSI – Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 13,785 shares of the company’s stock, valued at approximately $37,000.
Other hedge funds have also made changes to their positions in the company. Barclays PLC increased its holdings in Quantum-Si by 210.5% during the third quarter. Barclays PLC now owns 196,826 shares of the company’s stock valued at $173,000 after buying an additional 133,438 shares during the period. Geode Capital Management LLC raised its position in shares of Quantum-Si by 6.7% in the 3rd quarter. Geode Capital Management LLC now owns 2,316,921 shares of the company’s stock worth $2,044,000 after acquiring an additional 145,091 shares in the last quarter. SG Americas Securities LLC lifted its stake in shares of Quantum-Si by 12.4% during the 4th quarter. SG Americas Securities LLC now owns 67,588 shares of the company’s stock worth $182,000 after purchasing an additional 7,470 shares during the last quarter. Abel Hall LLC bought a new stake in Quantum-Si during the fourth quarter valued at about $28,000. Finally, Rhumbline Advisers grew its stake in Quantum-Si by 3.7% in the fourth quarter. Rhumbline Advisers now owns 148,946 shares of the company’s stock valued at $402,000 after purchasing an additional 5,298 shares during the last quarter. 39.90% of the stock is currently owned by hedge funds and other institutional investors.
Insider Buying and Selling at Quantum-Si
In other news, CEO Jeffrey Alan Hawkins sold 23,707 shares of the stock in a transaction dated Friday, March 21st. The stock was sold at an average price of $1.39, for a total value of $32,952.73. Following the transaction, the chief executive officer now directly owns 2,646,716 shares of the company’s stock, valued at approximately $3,678,935.24. This represents a 0.89 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. In the last quarter, insiders have sold 36,650 shares of company stock worth $50,944. 30.04% of the stock is owned by corporate insiders.
Quantum-Si Stock Up 3.7 %
Analyst Ratings Changes
A number of research firms have recently weighed in on QSI. National Bankshares set a $3.65 price target on shares of Quantum-Si in a report on Wednesday, March 5th. Alliance Global Partners restated a “buy” rating on shares of Quantum-Si in a research note on Wednesday, March 5th. Finally, HC Wainwright reaffirmed a “buy” rating and set a $5.50 price target on shares of Quantum-Si in a research report on Tuesday, January 14th.
Check Out Our Latest Stock Analysis on QSI
About Quantum-Si
Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). The company's platform is comprised of the Platinum NGPS instrument; the Platinum Analysis Software service; and reagent kits and semiconductor chips for use with its instruments.
Further Reading
- Five stocks we like better than Quantum-Si
- Health Care Stocks Explained: Why You Might Want to Invest
- How to Invest in Micro-Cap Stocks Like a Pro
- What Are the U.K. Market Holidays? How to Invest and Trade
- Investors Sell Microsoft Stock on OpenAI News—Time to Buy?
- How to Find Undervalued Stocks
- Take-Two Interactive: A Defensive Play Set to Explode
Want to see what other hedge funds are holding QSI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Quantum-Si incorporated (NASDAQ:QSI – Free Report).
Receive News & Ratings for Quantum-Si Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quantum-Si and related companies with MarketBeat.com's FREE daily email newsletter.